The Trump administration has capped indirect costs for National Institutes of Health research grants at 15%. That would wipe ...
Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results